News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

No Picture
News

ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer’s Disease Biomarker Research

October 7, 2026 SDBN Comments Off on ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer’s Disease Biomarker Research

Expanded Broadens Use of ALZpath’s Proprietary pTau217 Antibody Technology Across the Quanterix Simoa® Research Portfolio CARLSBAD, Calif., Oct. 7, 2026 /PRNewswire/ — ALZpath, Inc., a leader in blood test-based diagnostic solutions for Alzheimer’s disease, today […]


ADVERTISEMENT — Advertise With Biotech Networks
News

InflammaSense Named Performer on ARPA-H’s up to $38 Million CIRCLE Award to Advance Real-Time Immune Monitoring in Critical Care

October 7, 2026 SDBN Comments Off on InflammaSense Named Performer on ARPA-H’s up to $38 Million CIRCLE Award to Advance Real-Time Immune Monitoring in Critical Care

Company will measure autonomic and inflammatory signatures in up to 200 critically ill patients using its VITALx-patch wearable sensor and ARC cascade-endotyping classifier LA JOLLA, Calif., Oct. 7, 2026 /PRNewswire/ — InflammaSense, Inc., a pre-revenue […]

No Picture
News

Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology

October 6, 2026 SDBN Comments Off on Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology

Expanded agreement increases argenx’s exclusive access to ENHANZE® from six to eight targets SAN DIEGO, Oct. 6, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme” or the “Company”) today announced that it has expanded […]


ADVERTISEMENT — Advertise With Biotech Networks
News

The Epitranscriptome Heads Toward Clinical Necessity

October 6, 2026 SDBN Comments Off on The Epitranscriptome Heads Toward Clinical Necessity

A deep understanding of epitranscriptomics—RNA modifications—is the missing layer in the quest for more broadly effective precision medicines. That’s the view of Gudrun Stengel, PhD, CEO of Alida Biosciences, and the foundational belief that drives her […]

News

REVA Medical Announces Successful MOTIV® Live Case Demonstration and Late-Breaking BTK Trial Results at VIVA26

October 6, 2026 SDBN Comments Off on REVA Medical Announces Successful MOTIV® Live Case Demonstration and Late-Breaking BTK Trial Results at VIVA26

Live case showcases successful below-the-knee revascularization with two MOTIV® scaffolds; late-breaking analysis shows higher efficacy endpoint rates with MOTIV versus balloon angioplasty in both Rutherford 4 and Rutherford 5 CLTI populations SAN DIEGO, Oct. 6, […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

October 6, 2026 SDBN Comments Off on Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

Study to Explore Oral Maintenance Dosing Regimens Following Initial Weight Loss with Subcutaneous VK2735 Monthly and Every-Other-Week Subcutaneous Regimens to also be Evaluated SAN DIEGO, Oct. 6, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Iambic Submits IND for a Potentially Brain-Penetrant KIF18A Inhibitor IAM217, Its Second Wholly Owned AI-Discovered Candidate

October 5, 2026 SDBN Comments Off on Iambic Submits IND for a Potentially Brain-Penetrant KIF18A Inhibitor IAM217, Its Second Wholly Owned AI-Discovered Candidate

SAN DIEGO–(BUSINESS WIRE)–Iambic Therapeutics, Inc. (Iambic), a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food […]

No Picture
News

New Peer-Reviewed Study Demonstrates Amprion's Seed Amplification Assay Can Differentiate Multiple System Atrophy from Parkinson's Disease Using Skin Biopsy Samples

October 5, 2026 SDBN Comments Off on New Peer-Reviewed Study Demonstrates Amprion's Seed Amplification Assay Can Differentiate Multiple System Atrophy from Parkinson's Disease Using Skin Biopsy Samples

SAN DIEGO–(BUSINESS WIRE)–Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced publication of new peer-reviewed research in npj Parkinson’s Disease, a Nature Portfolio journal, demonstrating that its skin-based ?-synuclein […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Civil Rights and Trial Attorney John Gomez Announces Wrongful Death Lawsuit After Developmentally Disabled Man Killed at Fallbrook Care Facility

October 2, 2026 SDBN Comments Off on Civil Rights and Trial Attorney John Gomez Announces Wrongful Death Lawsuit After Developmentally Disabled Man Killed at Fallbrook Care Facility

Gomez Trial Attorneys and the family of Ryan Radabaugh allege Stepping Stone Resources failed to protect the 53-year-old despite an earlier warning involving its parking lot SAN DIEGO, Oct. 2, 2026 /PRNewswire/ — Civil Rights […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026

October 2, 2026 SDBN Comments Off on Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026

SAN DIEGO–(BUSINESS WIRE)—- $TVTX–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that it will share nine new data presentations, including five oral presentations, at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, CO, […]

News

JETSET Pilates Announces Grand Opening in Liberty Station, Bringing Premium Reformer Pilates to San Diego

October 1, 2026 SDBN Comments Off on JETSET Pilates Announces Grand Opening in Liberty Station, Bringing Premium Reformer Pilates to San Diego

Local musician Sean O’Donnell and wife Erin bring JETSET’s music-driven Pilates concept to the San Diego community SAN DIEGO, Oct. 1, 2026 /PRNewswire/ — JETSET Pilates, the fast-growing modern Reformer Pilates franchise offering premium, full-body […]


ADVERTISEMENT — Advertise With Biotech Networks
News

PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation

October 1, 2026 SDBN Comments Off on PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation

SAN DIEGO, Oct. 1, 2026 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit has been filed concerning certain investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT). Investors who purchased shares of PROCEPT BioRobotics Corporation […]

No Picture
News

ViroMissile Completes First Dose Cohort of Phase I Trial of Intravenously-Dosed IDOV-2; Safety Review Committee Clears Advancement to Next Cohort

October 1, 2026 SDBN Comments Off on ViroMissile Completes First Dose Cohort of Phase I Trial of Intravenously-Dosed IDOV-2; Safety Review Committee Clears Advancement to Next Cohort

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) — ViroMissile, Inc., a cancer immunotherapy company pioneering the IDOV™ (Intravenously Deliverable Oncolytic Virus) platform, today announced the completion of the first dose cohort in its ongoing first-in-human […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Is Anyone Out There?

October 1, 2026 SDBN Comments Off on Is Anyone Out There?

Curiosity drives almost all of us, and little sparks the imagination more than thinking about who might live among the stars. Click here to view original post Click Here to Publish/Feature Your Company or Product […]

News

Can Eyewear Close the Hearing Gap?

September 30, 2026 SDBN Comments Off on Can Eyewear Close the Hearing Gap?

The UC San Diego-incubated startup is recruiting local participants to test its AI-enabled prototypes. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks
News

Qualia Launches Qualia Perimenopause, a One Capsule Formula to Relieve All Common Perimenopause Symptoms

September 30, 2026 SDBN Comments Off on Qualia Launches Qualia Perimenopause, a One Capsule Formula to Relieve All Common Perimenopause Symptoms

Just one capsule a day, and a 28-day human study demonstrating promising results. CARLSBAD, Calif., Sept. 30, 2026 /PRNewswire/ — Women experience perimenopause in a multitude of ways: unpredictable hot flashes, sleep disruption, irritable mood […]

No Picture
News

EpiSign Launches METRIC 5-base, Enabling Comprehensive Episignature Analysis Across Genome-Sequencing Platforms

September 30, 2026 SDBN Comments Off on EpiSign Launches METRIC 5-base, Enabling Comprehensive Episignature Analysis Across Genome-Sequencing Platforms

New software extends automated analysis of more than 300 episignature disorders beyond methylation microarrays to Illumina 5-base, PacBio HiFi and Oxford Nanopore sequencing data LONDON, ON, Sept. 30, 2026 /PRNewswire/ — EpiSign Inc. today announced […]

No Picture
News

Prostate Cancer Foundation’s 33rd Annual Scientific Retreat Convenes Leading Experts in Prostate Cancer Research and Care

September 30, 2026 SDBN Comments Off on Prostate Cancer Foundation’s 33rd Annual Scientific Retreat Convenes Leading Experts in Prostate Cancer Research and Care

LOS ANGELES–(BUSINESS WIRE)–The Prostate Cancer Foundation (PCF) will convene leading researchers, clinicians and industry experts at its 33rd Annual Scientific Retreat, October 2–4, 2026, in Carlsbad, California. The Retreat is the world’s foremost scientific conference […]